Advertisement
Table 1 The clinical characteristics of the new-onset untreated SLE patients (n = 90)
| Variable | SLE patients |
|---|---|
| Gender (female/male, n) | 76/14 |
| Age (mean ± SD, year) | 33.1 ± 9.8 |
| Disease duration (mean ± SD, days) | 72.0 ± 53.0 |
| SLEDAI (mean ± SD) | 12.9 ± 7.9 |
| Disease activity | |
| SLEDAI ≤ 8, (n, %) | 40, (44.4) |
| SLEDAI > 8, (n, %) | 50, (55.6) |
| Disease manifestations | |
| Arthritis (n, %) | 41, (45.6) |
| Rash (n, %) | 43, (47.8) |
| Oral ulcer (n, %) | 11, (5.0) |
| Serositis (n, %) | 16, (17.8) |
| Photosensitivity (n, %) | 14, (15.6) |
| Raynaud’s phenomenon (n, %) | 5, (5.6) |
| Hematological (n, %) | 46, (51.1) |
| Lupus nephritis (proteinuria ≥ 0.5 g/24 h) (n, %) | 21, (23.3) |
| Neuropsychiatric manifestations (n, %) | 8, (8.9) |
| Autoantibody profile | |
| Anti-dsDNA + (n, %) | 75, (83.3) |
| Anti-Sm + (n, %) | 21, (23.3) |
| Anti-SSA + (n, %) | 42, (46.7) |
| Anti-SSB + (n, %) | 13, (14.4) |
| Anti-U1RNP + (n, %) | 29, (32.2) |
| Anti-Rib-P + (n, %) | 15, (16.7) |
| Anti-nucleosome-A + (n, %) | 36, (40.0) |
